217 related articles for article (PubMed ID: 1487550)
1. The effect of antacid and ranitidine on droxicam pharmacokinetics.
Bartlett A; Costa A; Martínez L; Roser R; Sagarra R; Sánchez J
J Clin Pharmacol; 1992 Dec; 32(12):1115-9. PubMed ID: 1487550
[TBL] [Abstract][Full Text] [Related]
2. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
[TBL] [Abstract][Full Text] [Related]
3. A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics.
Maya MT; Pais JP; Ruas Da Silva J; Morais JA
Eur J Drug Metab Pharmacokinet; 1995; 20(4):275-9. PubMed ID: 8983932
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
Stass H; Böttcher MF; Ochmann K
Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
[TBL] [Abstract][Full Text] [Related]
5. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic profile of droxicam.
Martínez L; Sánchez J
Eur J Rheumatol Inflamm; 1991; 11(4):10-4. PubMed ID: 1365484
[TBL] [Abstract][Full Text] [Related]
7. Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects.
Kubitza D; Becka M; Zuehlsdorf M; Mueck W
J Clin Pharmacol; 2006 May; 46(5):549-58. PubMed ID: 16638738
[TBL] [Abstract][Full Text] [Related]
8. Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
Ford SL; Wire MB; Lou Y; Baker KL; Stein DS
Antimicrob Agents Chemother; 2005 Jan; 49(1):467-9. PubMed ID: 15616339
[TBL] [Abstract][Full Text] [Related]
9. Effect of antacid suspension on the pharmacokinetics of ibuprofen.
Gontarz N; Small RE; Comstock TJ; Stalker DJ; Johnson SM; Willis HE
Clin Pharm; 1987 May; 6(5):413-6. PubMed ID: 3665393
[TBL] [Abstract][Full Text] [Related]
10. Lack of pharmacokinetic interaction between linezolid and antacid in healthy volunteers.
Grunder G; Zysset-Aschmann Y; Vollenweider F; Maier T; Krähenbühl S; Drewe J
Antimicrob Agents Chemother; 2006 Jan; 50(1):68-72. PubMed ID: 16377669
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers.
Martínez L; Sánchez J; Roser R; García-Barbal J; Bartlett A; Estruch J; Sagarra R; Puig S; Costa A
Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):729-37. PubMed ID: 3221746
[TBL] [Abstract][Full Text] [Related]
12. Influence of antacid and ranitidine on the pharmacokinetics of oral cefetamet pivoxil.
Blouin RA; Kneer J; Ambros RJ; Stoeckel K
Antimicrob Agents Chemother; 1990 Sep; 34(9):1744-8. PubMed ID: 1981000
[TBL] [Abstract][Full Text] [Related]
13. Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin.
Nix DE; Watson WA; Lener ME; Frost RW; Krol G; Goldstein H; Lettieri J; Schentag JJ
Clin Pharmacol Ther; 1989 Dec; 46(6):700-5. PubMed ID: 2598571
[TBL] [Abstract][Full Text] [Related]
14. The effect of concomitantly administered antacids on the bioavailability of lornoxicam, a novel highly potent NSAID.
Dittrich P; Radhofer-Welte S; Magometschnigg D; Kukovetz WR; Mayerhofer S; Ferber HP
Drugs Exp Clin Res; 1990; 16(2):57-62. PubMed ID: 2401187
[TBL] [Abstract][Full Text] [Related]
15. The influence of gastric emptying on droxicam pharmacokinetics.
Sánchez J; Martínez L; García-Barbal J; Roser R; Bartlett A; Sagarra R
J Clin Pharmacol; 1989 Aug; 29(8):739-45. PubMed ID: 2778095
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
Propst A; Propst T; Judmaier G
Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel bioavailability: absence of influence of food or antacids.
McEwen J; Strauch G; Perles P; Pritchard G; Moreland TE; Necciari J; Dickinson JP
Semin Thromb Hemost; 1999; 25 Suppl 2():47-50. PubMed ID: 10440423
[TBL] [Abstract][Full Text] [Related]
18. Effect of an antacid on gastrointestinal absorption of theophylline.
Arnold LA; Spurbeck GH; Shelver WH; Henderson WM
Am J Hosp Pharm; 1979 Aug; 36(8):1059-62. PubMed ID: 484565
[TBL] [Abstract][Full Text] [Related]
19. Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid.
Desager JP; Harvengt C
J Int Med Res; 1989; 17(1):62-7. PubMed ID: 2565267
[TBL] [Abstract][Full Text] [Related]
20. Reduced oral itraconazole bioavailability by antacid suspension.
Lohitnavy M; Lohitnavy O; Thangkeattiyanon O; Srichai W
J Clin Pharm Ther; 2005 Jun; 30(3):201-6. PubMed ID: 15896236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]